By Lynn Eaton2000-09-07T00:00:00
Scottish biotechnology firm Rosgen has announced that it does not plan to charge the NHS for carrying out tests for mutations in two genes linked to breast cancer.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud